Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - March 2021

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Beclometasone / formoterol / glycopyrronium (Trimbow®) has been accepted for use as a maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - March 2021' on Email Share 'SMC Update - March 2021' on Delicious Share 'SMC Update - March 2021' on Digg Share 'SMC Update - March 2021' on Facebook Share 'SMC Update - March 2021' on reddit Share 'SMC Update - March 2021' on Twitter

atomic-wealth

No Comments to “SMC Update - March 2021”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

vipers